Sofia Töyrä Silfverswärd

466 citations
25 papers · 341 indexed · h-index 11

Sofia Töyrä Silfverswärd

22 papers receiving 338 citations

Peers

Sofia Töyrä Silfverswärd
Comparison fields: 5 of 68
  • Immunology 128
  • Molecular Biology 105
  • Rheumatology 84
  • Oncology 57
  • Cancer Research 43
Replace T. Okano with:
T. Okano Japan
Ahmet Arman Türkiye
Haritz Irizar Spain
Prameladevi Chinnasamy United States
Ljiljana Luković Serbia
Ádám Bartos United States
David Kinsley United States
Sally A. Clayton United Kingdom
Ekaterina Zezina Germany
Sofia Töyrä Silfverswärd relative to T. Okano Japan T. Okano's profile →
Citations per field
00.5×1.5×
T. Okano · 1×
Citations per year

Countries citing papers authored by Sofia Töyrä Silfverswärd

Since Specialization
Citations

This map shows the geographic impact of Sofia Töyrä Silfverswärd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Töyrä Silfverswärd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Töyrä Silfverswärd more than expected).

Fields of papers citing papers by Sofia Töyrä Silfverswärd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Töyrä Silfverswärd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Töyrä Silfverswärd. The network helps show where Sofia Töyrä Silfverswärd may publish in the future.

Co-authorship network of co-authors of Sofia Töyrä Silfverswärd

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Töyrä Silfverswärd. A scholar is included among the top collaborators of Sofia Töyrä Silfverswärd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Töyrä Silfverswärd. Sofia Töyrä Silfverswärd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 5
5 8
6 4
7 7
8 1
9 4
10 11
11 21
12 20
13 1
14 33
15 41
16 59
17 16
18 18
19 26
20 19

About Sofia Töyrä Silfverswärd

Sofia Töyrä Silfverswärd is a scholar working on Immunology, Cancer Research and Oncology, having authored 25 papers that have together received 341 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Immunology (128 citations), Rheumatology (84 citations) and Biological Psychiatry (9 citations). Sofia Töyrä Silfverswärd has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Malin C. Erlandsson, Maria Bokarewa, Karin Andersson, Minna Turkkila, Caroline Wasén, Rille Pullerits, Mikael Brisslert, Apostolos Bossios, Linda Ekerljung and Bo Lundbäck. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026